A detailed history of Lafayette Investments, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lafayette Investments, Inc. holds 2,935 shares of GILD stock, worth $258,514. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,935
Previous 2,935 -0.0%
Holding current value
$258,514
Previous $201,000 22.39%
% of portfolio
0.05%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$73.27 - $83.09 $18,317 - $20,772
250 Added 9.31%
2,935 $237,000
Q4 2022

Jan 24, 2023

BUY
$62.32 - $89.47 $167,329 - $240,226
2,685 New
2,685 $0

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Lafayette Investments, Inc. Portfolio

Follow Lafayette Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lafayette Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lafayette Investments, Inc. with notifications on news.